Dimerix

Dimerix Asset Growth

The Year-over-Year Total Asset Growth of Dimerix (DXB.AX) as of Oct 27, 2026 is -35.74 %. In the previous year, Year-over-Year Total Asset Growth was 184.23 % — a change of -119.40% (lower).

Asset Growth

-35.74 %

YoY

-119.40%

Last updated:

Year-over-Year Total Asset Growth of Dimerix is 2026 -35.74 % . Year-over-Year Total Asset Growth of Dimerix was 2025 184.23 % . It decreases by -119.40% lower compared to the previous year.

The Dimerix Asset Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Asset Growth
Date
Asset Growth
Jan 1, 2019
-31.99 AUD
Jan 1, 2020
110.28 AUD
Jan 1, 2021
-9.32 AUD
Jan 1, 2022
75.11 AUD
Jan 1, 2023
7.64 AUD
Jan 1, 2024
80.65 AUD
Jan 1, 2025
184.23 AUD
Jan 1, 2026
-35.74 AUD
The Dimerix Asset Growth history
YEARAsset GrowthYoY
-35.74 %-119.40%
184.23 %+128.44%
80.65 %+955.50%
7.64 %-89.83%
75.11 %-905.91%
-9.32 %-108.45%
110.28 %-444.71%
-31.99 %-120.91%
152.97 %+1,014.85%
13.72 %-191.86%
-14.94 %-121.81%
68.47 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dimerix Stock analysis

What does Dimerix do? Dimerix Ltd is an Australian biotechnology company specializing in the development of innovative therapies for various medical needs. Their business model is based on identifying new targets for drug development, often through collaborations with other biotech or pharmaceutical companies. Dimerix focuses on cancer therapy, utilizing their innovative platform technology to identify and test a variety of drug candidates. They also have a pipeline of medications for kidney and lung diseases, as well as inflammation and pain. Dimerix actively seeks partnerships with other companies and research institutions to bring innovative therapies to market. One of their key products, DMX-200, is currently in phase II clinical trials for the treatment of kidney diseases and has shown promising results. Overall, Dimerix is well-positioned to continue bringing successful therapies to market in the future. Dimerix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dimerix stock

Year-over-Year Total Asset Growth of Dimerix is -35.74 % in 2026.

On Eulerpool you can find the complete historical development of Year-over-Year Total Asset Growth Dimerix since 2006 – with annual values, charts, and detailed analysis.

Asset growth measures the percentage change in total assets. Rapid asset growth may indicate expansion but can also correlate with lower future returns.

To evaluate Year-over-Year Total Asset Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Total Asset Growth.

Year-over-Year Total Asset Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Total Asset Growth's Dimerix historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Dimerix

All Key Metrics — Dimerix